A no-reflow prediction model in patients with ST-elevation acute myocardial infarction and primary drug-eluting stenting

Scandinavian Cardiovascular Journal

Volumn 45, Issue 2, 2011, Pages 98-104

  Wang, Chang Hua ^a   Chen, Yun Dai ^a   Yang, Xin Chun ^b   Wang, Le Feng ^b   Wang, Hong Shi ^b   Sun, Zhi Jun ^a   Liu, Hong Bin ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Acute myocardial infarction; no refl ow; primary drug eluting stenting

Indexed keywords

GLUCOSE;

ADULT; AGED; ANGIOCARDIOGRAPHY; AORTA BALLOON; ARTERY THROMBOSIS; ARTICLE; COLLATERAL CIRCULATION; CONTROLLED STUDY; DRUG ELUTING STENT; FEMALE; GLUCOSE BLOOD LEVEL; HEART MUSCLE REPERFUSION; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NO REFLOW PHENOMENON; PERCUTANEOUS CORONARY INTERVENTION; PREDICTOR VARIABLE; PRIORITY JOURNAL; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STATISTICAL ANALYSIS; UNIVARIATE ANALYSIS;

AGE FACTORS; AGED; ANGIOPLASTY, BALLOON, CORONARY; BLOOD GLUCOSE; COLLATERAL CIRCULATION; DRUG-ELUTING STENTS; FEMALE; HUMANS; INTRA-AORTIC BALLOON PUMPING; MALE; MIDDLE AGED; MODELS, CARDIOVASCULAR; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; NO-REFLOW PHENOMENON; PREOPERATIVE CARE; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; THROMBOSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 79952577425     PISSN: 14017431     EISSN: 16512006     Source Type: Journal    
DOI: 10.3109/14017431.2011.558209     Document Type: Article

References (28)

1. Rezkalla SH, Kloner RA. Coronary no-refl ow phenomenon: From the experimental laboratory to the cardiac catheteri-zation laboratory. Catheter Cardiovasc Interv. 2008;72: 950-7.
2. Brosh D, Assali AR, Mager A, Porter A, Hasdai D, Teplitsky I, et al. Effect of no-refl ow during primary percutaneous coronary intervention for acute myocardial infarction on six-month mortality. Am J Cardiol. 2007;99:442-5. (Pubitemid 46223482)
3. Henriques JP, Zijlstra F, Ottervanger JP, de Boer MJ, van't Hof AW, Hoorntje JC, et al. Incidence and clinical signifi-cance of distal embolization during primary angioplasty for acute myocardial infarction. Eur Heart J. 2002;23:1112-7. (Pubitemid 35230716)
4. Svilaas T, Vlaar PJ, van der Horst IC, Diercks GF, de Smet BJ, van den Heuvel AF, et al. Thrombus aspiration during primary percutaneous coronary intervention. N Engl J Med. 2008;358:557-67. (Pubitemid 351214283)
5. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31-41.
6. TIMI Study Group. The Thrombolysis in Myocardial Infarction (TIMI) trial. N Engl J Med. 1985;312:932-6.
7. Van't Hof AW, Liem A, Suryapranata H, Hoorntje JC, de Boer MJ, Zijlstra F. Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: Myocardial blush grade. Circulation. 1998;97:2302-6. (Pubitemid 28280383)
8. Rentrop KP, Cohen M, Blanke H, Phillips RA. Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects. J Am Coll Cardiol. 1985;5:587-92. (Pubitemid 15141963)
9. Gibson CM, de Lemos JA, Murphy SA, Marble SJ, McCabe CH, Cannon CP, et al. TIMI Study Group; Combination therapy with abciximab reduces angiographi-cally evident thrombus in acute myocardial infarction: A TIMI 14 substudy. Circulation. 2001;103:2550-4. (Pubitemid 32521963)
10. Ndrepepa G, Mehilli J, Schulz S, Iijima R, Keta D, A. Byrne R, et al. Prognostic significance of epicardial blood fl ow before and after percutaneous coronary intervention in patients with acute coronary syndromes. J Am Coll Cardiol. 2008;52:512-7.
11. Reffelmann T, Kloner RA. The no-refl ow phenomenon: Basic science and clinical correlates. Heart. 2002;87:162-8. (Pubitemid 34098385)
12. Singh M, Mathew V, Garratt KN, Berger PB, Grill DE, Bell MR, et al. Effect of age on the outcome of angioplasty for acute myocardial infarction among patients treated at the Mayo Clinic. Am J Med. 2000;108:187-92. (Pubitemid 30100609)
13. Lowe GD, Rumley A, Woodward M, Morrison CE, Philippou H, Lane DA, et al. Epidemiology of coagulation factors, inhibitors and activation markers: The Third Glasgow MONICA Survey I. Illustrative reference ranges by age, sex, and hormone use. Br J Haematol. 1997;97:775-84. (Pubitemid 27321375)
14. Kirma C, Izgi A, Dundar C, Tanalp AC, Oduncu V, Aung SM, et al. Clinical and procedural predictors of no-refl ow phenomenon after Primary percutaneous coronary interventions. Circ J. 2008;72:716-21. (Pubitemid 351716675)
15. Hearse DJ, Bolli R. Reperfusion induced injury: Manifestations, mechanisms, and clinical relevance. Cardiovasc Res. 1992;26:101-8.
16. Nagata Y, Usuda K, Uchiyama A. Pathological analysis of intracoronary thrombus (thrombectomy catheter samples) in acute myocardial infarction. Kokyu to Jyunkan. 2002;50: 315-20.
17. Iwakura K, Ito H, Ikushima M, Kawano S, Okamura A, Asano K, et al. Association between hyperglycemia and the no-refl ow phenomenon in patients with acute myocardial infarction. J Am Coll Cardiol. 2003;41:1-7. (Pubitemid 36044395)
18. Hokama JY, Ritter LS, Davis-Gorman G, Cimetta AD, Copeland JG, McDonagh PF. Diabetes enhances leukocyte accumulation in the coronary microcirculation early in reper-fusion following ischemia. J Diabetes Complications. 2000; 14:96-107. (Pubitemid 30665760)
19. Undas A, Wiek I, St ê pien E, Zmudka K, Tracz W. Hyperglycemia is associated with enhanced thrombin formation, platelet activation, and fibrin clot resistance to lysis in patients with acute coronary syndrome. Diabetes Care. 2008;31:1590-5.
20. Hassouna A, Loubani M, Matata BM, Fowler A, Standen NB, Galiñanes M. Mitochondrial dysfunction as the cause of the failure to precondition the diabetic human myocardium. Cardiovasc Res. 2006;69:450-8. (Pubitemid 43098801)
21. Marfella R, Siniscalchi M, Esposito K, Sellitto A, De Fanis U, Romano C, et al. Effects of stress hyperglycemia on acute myocardial infarction: Role of infl ammatory immune process in functional cardiac outcome. Diabetes Care. 2003;26: 3129-35. (Pubitemid 37339509)
22. Reimer KA, Jennings RB, Cobb FR, Murdock RH, Greenfield JC Jr, Becker LC, et al. Animal models for protecting ischemic myocardium: Results of the NHLBI Cooperative Study. Comparison of unconscious and conscious dog models. Circ Res. 1985;56:651-5.
23. Desch S, Eitel I, Schmitt J, Sareban M, Fuernau G, Schuler G, et al. Effect of coronary collaterals on microvas-cular obstruction as assessed by magnetic resonance imaging in patients with acute ST-elevation myocardial infarction treated by primary coronary intervention. Am J Cardiol. 2009;104:1204-9.
24. Yip HK, Chen MC, Chang HW, Hang CL, Hsieh YK, Fang CY, et al. Angiographic morphologic features of infarct-related arteries and timely reperfusion in acute myocardial infarction. Chest. 2002;122:1322-32.
25. Albertal M, Cura F, Escudero AG, et al. Relationship between collateral circulation and successful myocardial reperfu-sion in acute myocardial infarction: A subanalysis of the PREMIAR Trial. Angiology. 2008;59:587-92.
26. Albertal M, Cura F, Escudero AG, Padilla LT, Thierer J, Trivi M, et al. Should we emergently revascularize occluded coronaries for cardiogenic shock. JAMA. 2001;285:190-2.
27. Summers WK, Jamison RL. The no refl ow phenomenon in renal ischemia. Lab Invest. 1971;25:635-43.
28. De Luca G, Gibson CM, Huber K, Zeymer U, Dudek D, Cutlip D, et al. Association between advanced Killip class at presentation and impaired myocardial perfusion among patients with ST-segment elevation myocardial infarction treated with primary angioplasty and adjunctive glyco-proteinb-a inhibitors. Am Heart J. 2009;158:416-21.